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ABSTRACT
Objective: To describe the prevalence of hepatic steatosis 
and to assess the performance of biochemical, anthropomet-
ric and body composition indicators for hepatic steatosis in 
obese teenagers.
Methods: Cross-sectional study including 79 adolecents 
aged from ten to 18 years old. Hepatic steatosis was diagnosed 
by abdominal ultrasound in case of moderate or intense hepa-
torenal contrast and/or a difference in the histogram ≥7 on the 
right kidney cortex. The insulin resistance was determined 
by the Homeostasis Model Assessment–Insulin Resistance 
(HOMA-IR) index for values >3.16. Anthropometric and 
body composition indicators consisted of body mass index, 
body fat percentage, abdominal circumference and subcu-
taneous fat. Fasting glycemia and insulin, lipid profile and 
hepatic enzymes, such as aspartate aminotransferase, alanine 
aminotransferase, gamma-glutamyltransferase and alkaline 
phosphatase, were also evaluated. In order to assess the perfor-
mance of these indicators in the diagnosis of hepatic steatosis 
in teenagers, a ROC curve analysis was applied.
Results: Hepatic steatosis was found in 20% of the patients 
and insulin resistance, in 29%. Gamma-glutamyltrans-
ferase  and HOMA-IR were good indicators for predicting 
hepatic steatosis, with a cutoff of 1.06 times above the refer-
ence value for gamma-glutamyltransferase and 3.28 times for 
the HOMA-IR. The anthropometric indicators, the body fat 
percentage, the lipid profile, the glycemia and the aspartate 
aminotransferase did not present significant associations. 
Conclusions: Patients with high gamma-glutamyl-
transferase level and/or HOMA-IR should be submitted 
to abdominal ultrasound examination due to the increased 
chance of having hepatic steatosis.
Key-words: fatty liver; obesity; adolescent; enzymes.
RESUMO 
Objetivo: Descrever a prevalência da esteatose hepática e 
avaliar o desempenho de indicadores bioquímicos, antropo-
métricos e de composição corporal para identificar a doença 
em adolescentes obesos. 
Métodos: Estudo transversal com 79 adolescentes de dez 
a 18 anos. Diagnosticou-se a esteatose hepática por ultrassom 
abdominal em caso de contraste hepatorrenal moderado ou in-
tenso e/ou diferença no histograma ≥7 em relação ao córtex do 
rim direito. Determinou-se a resistência à insulina pelo índice 
Homeostasis Model Assessment–Insulin Resistance (HOMA-IR) para 
valores >3,16. Os indicadores antropométricos e de composição 
corporal foram: índice de massa corpórea, porcentagem de gor-
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dura corporal, circunferência abdominal e gordura subcutânea. 
Dosaram-se glicemia e insulina de jejum, perfil lipídico e enzimas 
hepáticas aspartato aminotransferase, alanina aminotransferase, 
gama-glutamiltransferase e fosfatase alcalina. Aplicou-se a curva 
ROC para avaliar o desempenho dos indicadores para identificar 
adolescentes com esteatose hepática. 
Resultados: A esteatose hepática esteve presente em 
20% dos pacientes e a resistência à insulina, em 29%. 
A gama-glutamiltransferase e o HOMA-IR mostraram-se 
bons  indicadores para predizer a esteatose hepática, com 
ponto de corte de 1,06 vezes acima do valor de referência 
para a gama-glutamiltransferase e de 3,28 para o HOMA-IR. 
Os indicadores antropométricos, a porcentagem de gordura 
corporal, o perfil lipídico, a glicemia e a aspartato amino-
transferase não apresentaram diferenças significantes. 
Conclusões: Pacientes com elevação de gama-glutamil-
transferase e/ou HOMA-IR devem ser submetidos ao exame 
de ultrassom abdominal, havendo grande probabilidade de 
se obter como resultado a esteatose hepática. 
Palavras-chave:  fígado gorduroso; obesidade; 
adolescente; enzimas.
RESUMEN 
Objetivo: Describir la prevalencia de la esteatosis he-
pática y evaluar el desempeño de indicadores bioquímicos, 
antropométricos y de composición corporal para identificar 
la enfermedad en adolescentes obesos. 
Métodos: Estudio transversal con 79 adolescentes de 10 a 18 
años. Se diagnosticó la esteatosis hepática por ultrasonido abdo-
minal en caso de contraste hepatorrenal moderado o intenso y/o 
diferencia en el histograma ≥7 con relación al córtex del riñón 
derecho. Se determinó la resistencia a la insulina por el índice 
Homeostasis Model Assessment-Insulin Resistence (HOMA-IR) para 
valores >3,16. Los indicadores antropométricos y de composi-
ción corporal fueron índice de masa corporal, porcentaje de grasa 
corporal, circunferencia abdominal y grasa subcutánea. Se dosifi-
caron glucemia e insulina en ayuno, perfil lipídico y las encimas 
hepáticas aspartato aminotransferasa, alanina aminotransferasa, 
gama-glutamiltransferasa y fosfatasa alcalina. Se analizaron curvas 
ROC para evaluar el desempeño de los indicadores en identificar 
adolescentes con esteatosis hepática.
Resultados: La esteatosis hepática estuvo presente en el 
20% de los pacientes y la resistencia a la insulina, en el 29%. 
La gama-glutamiltransferasa y el HOMA-IR se mostraron 
buenos indicadores para predecir la esteatosis hepática, 
con punto de corte de 1,06 veces por encima del valor de 
referencia para la gama-glutamiltransferasa y de 3,28 para el 
HOMA-IR. Los indicadores antropométricos, el porcentaje 
de grasa corporal, el perfil lipídico, la glucemia y la aspartato 
aminotransferasa no presentaron diferencias significantes. 
Conclusiones: Pacientes con elevación de gama-glutamil-
transferasa y/o HOMA-IR deben ser sometidos al examen de 
ultrasonido abdominal con gran probabilidad de obtenerse 
como resultado la esteatosis hepática.
Palabras clave: hígado grasoso; obesidad; adolescente; encimas.
Introduction
The non-alcoholic fatty liver disease (NAFLD) is a clini-
copathological condition characterized by lipid accumulation 
inside the hepatocytes, whose spectrum of presentation rang-
es from a simple fatty infiltration of liver (steatosis), through 
the establishment of an inflammation (steatohepatisis), to 
fibrosis and hepatic cirrhosis. The pathologic condition is 
similar to that of the alcohol-induced lesion, but it occurs 
in individuals without significant alcohol consumption(1).
NAFLD occurs mainly in obese individuals and it is an increas-
ing problem in children and adolescents, given the increasing 
prevalence of childhood obesity. The hepatic steatosis (HS) with 
onset in childhood and adolescence deserves special attention be-
cause most patients are asymptomatic and the evolution is silent(2).
The gold standard for the diagnosis of NAFLD is liver bi-
opsy; however, due to the difficulty of implementation and the 
risk of complications, indirect methods such as imaging and 
laboratory exams associated to the history and clinical exami-
nation, have been widely used in children and adolescents(3).
The difficulty to diagnose coupled with the small number of 
studies available makes the prevalence of HS still poorly known in 
the pediatric age group. HS seems to be primarily associated with 
obesity and insulin resistance (IR). With the significant increase 
in the prevalence of obesity in children and adolescents and the 
direct relationship of this nutritional disorder with the develop-
ment of HS, the present study aimed to describe the prevalence 
of HS diagnosed by abdominal ultrasonography and to evaluate 
the performance of biochemical, anthropometric, and body 
composition indicators in identifying HS in obese adolescents.
Method
We conducted a cross-sectional study with adolescents at-
tending the Child and Adolescent Obesity Outpatient Clinic at 
Hospital de Clínicas from the School of Medical Sciences within 
Universidade Estadual de Campinas (Unicamp). All adolescents 
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treated from April 2011 to May 2012 who presented body 
mass index (BMI) ≥P
97
 for age and sex, according to the charts 
of the Word Health Organization (WHO(4), were invited to 
participate in the research. We analyzed the clinical, laboratory, 
and ultrasonography characteristics of 79 patients of both sexes, 
from 10 to 18 years old, who were diagnosed with obesity and 
whose parents signed an informed consent form (ICF). 
Anthropometric techniques for measuring weight and height 
were those recommended by Lohman et al(5). We calculated BMI 
by the Quetelet index (BMI=weight/height2). Waist circum-
ference (WC) was measured in centimeters with tape measure 
(Sanny®), at the midpoint between the last rib and the superior 
border of the iliac crest. The percentage of body fat (%BF) was 
measured by dual energy X-ray absorptiometry (DXA), with 
Hologic® appliance, Discovery QDR Series n. 1005-75. 
Insulin resistance was diagnosed by Homeostasis Model 
Assessment-Insulin Resistance (HOMA-IR), which is the 
product of fasting insulin (mUI/mL) and fasting plasma 
glucose (mmol/L) divided by 22.5. Insulin Resistance was 
defined when the values were above 3.16(6).
We carried out the ultrasonography by a Toshiba device, 
Power Vision 6000, through sector transducers of 3.75MHz 
and 5MHz. All exams were performed by the same examiner, 
with the patient in supine position after fasting for 12 hours. 
The diagnosis of HS was considered in case of moderate or 
intense hepatorenal contrast and/or difference ≥7 on the histo-
gram of the relationship right lobe/cortex of the right kidney(7).
Subcutaneous fat (SF) was measured by ultrasonography, with 
a 7.5MHz linear transducer. The transducer was positioned in the 
middle at 1cm above the navel line, without exerting any pressure 
on the abdomen, in order not to underestimate the measurement. 
SF was measured as the distance (cm) between the skin and the 
outer face of the fascia of the rectus abdominis muscles(8).
For laboratorial analysis of the biochemical exams, blood 
samples by venipuncture were collected in the morning after fast-
ing for 12 hours. We analyzed fasting plasma glucose and lipid 
profile by enzymatic colorimetric; the measurement of aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) was 
performed by kinetic method ultraviolet (U.V.). For alkaline 
phosphatase (ALP) and gama-glutamil transferase (GGT), we 
used the colorimetric kinetic method, all with the Roche Di-
agnostics® Laboratory Reagent Kit. For determination of basal 
insulin, we used the reagents kit from the Siemens Healthcare 
Diagnostics® Laboratory by the method of chemiluminescence.
Furthermore, we calculated the fatty liver index (FLI), a 
simple predictor, which assesses the presence of HS in the 
general population, proposed by Bedogni et al(9) and validated 
for the adult population.
FLI=(e0,953*log(TG)+0,139*IMC+0,718*log(GGT)+0,053*WC-15,745)/(1+e0,953*l
og(TG)+0,139*IMC+0,718*log(GGT)+0,053*WC-15,745)*100, being WC: waist 
circumference; GGT: gama-glutamil transferase; TG: tri-
glycerides; log: logarithm; e: Euler. According to this index, 
it is considered HS when the value is ≥60.
We analyzed the data using the IBM Statistical Package 
for the Social Sciences (SPSS) version 20.0. The descriptive 
analysis of continuous variables included the calculation 
of means and their respective standard deviations; for cat-
egorical variables, their percentage values were calculated. 
We used the Kolmogorov-Smirnov to assess the normal-
ity of the distribution of studied variables. We used the 
Mann-Whitney test to compare two independent groups. 
The hypothesis of dependence between categorical variables 
was assessed using the chi-square or Fischer’s exact test, 
according to the expected frequencies. We calculated the 
values for Odds Ratio (OR) and their respective confidence 
intervals of 95% (95%CI) to assess the strength of depen-
dence between categorical variables.
The analysis of ROC curves (Receiver Operating Character-
istic Curve) was used to assess the performance of the anthro-
pometric and biochemical indicators in identifying adolescents 
with HS. Given the difference of values of the hepatic enzymes 
according to age and sex in the analyzed adolescents, the values 
of these enzymes were transformed in number of times the up-
per limit of normality (no x). That is, the result of the serum 
concentration of the hepatic enzyme was divided by the number 
of the reference value according to age and sex. We considered 
the reference value for each sex and age range and divided the 
value found by the reference value. We used as reference the 
values preconized by Roche Diagnostics(10). The areas under 
the ROC curves were calculated as proposed by Hanley and 
McNeil. We used a confidence interval of 95%. The sensibil-
ity and specificity values were calculated for all variables in the 
analysis of the ROC curves with significant results. The cutoff 
point with the highest sum of sensitivity and specificity was 
chosen to optimize the relationship between these two param-
eters, reflecting greater accuracy in diagnosis.
The Kappa (k) test was used as a measure of agreement be-
tween the ultrasound (US) and the FLI. The k value reflects the 
degree of concordance between the methods. Values  of k equal to 
1 indicate perfect agreement between both methods and values 
equal to zero  indicate no correlation between the tested methods.
The level of significance established as a basis for decision 
was lower than 5% (p<0.05) for all tests.
The study was approved by the Research Ethics Com-
mittee of Medical Sciences at Unicamp in December 2010, 
under protocol n. 872/2010. 
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Results
We evaluated 79 patients, being 39 (49.4%) female and 
40 (50.6%) male, aged between 10 and 18 years (mean 12.8), 
who attended the Child and Adolescent Obesity Outpatient 
Clinic of Hospital de Clínicas da Unicamp.
The HS diagnosed by abdominal ultrasonography was 
present in 16 patients (20.3%). The mean ALT, GGT, and 
ALP were significantly higher in patients with HS, as well 
as the HOMA-IR index. Indicators of body composition 
and lipid profile showed no significantly different among 
the groups with and without HS (Table 1).
Among the patients assessed, 23 (29.1%) presented IR, 
being 13 (56.5%) females and 10 (43.5%) males. Of the pa-
tients with diagnosis of IR, eight (34.8%) also had HS. The 
means for WC, BMI, SF and %BF were higher in patients 
who presented IR. Mean HDL-cholesterol was significantly 
lower in patients with IR (Table 2).
Hepatic steatosis Total  
(n=79) p-valueAbsent (n=63) Present (n=16)
Age (years) 12.9±2.4 12.1±1.9 12.8±2.3 0.254
Waist circumference (cm) 101.2±13.1 103.6±10.4 101.7±12.6 0.288
Body mass index (kg/m2) 31.9±5.3 32.6±5.1 32.0±5.26 0.661
Body fat (%) 41.8±5.2 40.6±5.0 41.6±5.1 0.538
Subcutaneous fat (cm) 4.2±1.0 4.2±1.1 4.2±1.0 0.683
Aspartate aminotransferase (nº x) 0.5±0.2 0.6±0.4 0.5±0.2 0.638
Alanine aminotransferase (nº x) 0.6±0.5 1.1±0.9 0.7±0.6 0.011
Gama-glutamil transferase (nº x) 0.7±0.5 1.0±0.4 0.8±0.5 0.008
Alkaline phosphatase (nº x) 0.7±0.2 0.8±0.3 0.7±0.2 0.047
Fasting glucose (mg/dL) 82.7±6.6 85.0±8.0 83.2±6.9 0.423
Fasting insulin (uUI/mL) 10.8±7.0 17.2±11.7 12.1±8.5 0.041
HOMA-IR 2.2±1.4 3.7±2.8 2.5±1.9 0.038
Total Cholesterol (mg/dL) 164.0±42.0 157.0±32.0 163.0±40.0 0.678
LDL-cholesterol (mg/dL) 103.0±39.0 92.0±22.0 101.0±36.0 0.294
HDL-cholesterol (mg/dL) 43.0±9.0 38.0±9.0 42.0±9.0 0.067
Triglycerides (mg/dL) 92.0±37.0 134.0±87.0 101.0±54.0 0.097
Hepatic fat content 52.49±3.46 68.56±5.90 55.7±27.4 0.031
Table 1 - Clinical and laboratory characteristics of obese patients with and without hepatic steatosis. Values presented as means 
and standard deviation
Mann-Whitney test for all variables; no x: number of times the upper limit of normality according to age and sex; HOMA-IR: Homeostasis Model 
Assessment–Insulin Resistance
Insulin resistance p-valueAbsent (n=56) Present (n=23)
Age (years) 12.81±2.46 12.84±2.14 0.750
Waist circumference (cm) 98.7±11.2 109.0±13.1 0.002
Body mass index (kg/m2) 30.67±4.61 35.39±5.33 0.001
Body fat (%) 40.3±5.1 44.7±3.6 0.001
Subcutaneous fat (cm) 4.03±0.97 4.84±1.15 0.003
Aspartate aminotransferase (nº x) 0.57±0.23 0.61±0.34 0.775
Alanine aminotransferase (nº x) 0.70±0.56 0.98±0.83 0.065
Gama-glutamyl transferase (nº x) 0.75±0.45 1.06±0.69 0.043
Alkaline Phosphatase (nº x) 0.74±0.28 0.70±0.27 0.514
Total cholesterol (mg/dL) 165.0±45.0 158.0±25.0 0.456
LDL-cholesterol (mg/dL) 102.0±41.0 98.0±20.0 0.706
HDL-cholesterol (mg/dL) 44.0±9.0 38.0±8.0 0.006
Triglycerides (mg/dL) 95.0±56.0 114.0±47.0 0.051
Table 2 - Characteristics of individuals evaluated according to insulin resistance
no x: number of times the upper limit of normal according to age and sex; Mann-Whitney test for all variables
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AUC: area under the curve; SE: standard error; ST: sensitivity; SP: specificity; 95%CI: confidence interval of 95%; no x: number of times the upper 
limit of normal according to age and sex; HOMA-IR: Homeostasis Model Assessment–Insulin Resistance
AAC±EP (95%CI) p-value Cutoff Point ST SP
Alanine aminotransferase (nº x) 0.707±0.064 (0.581–0.832) 0.011 0.54 93.7 49.2
Aspartate aminotransferase (nº x) 0.538±0.084 (0.373–0.703) 0.639 – – –
Gama-glutamil transferase (nº x) 0.715±0.074 (0.570–0.859) 0.008 1.06 62.5 80.9
Alkaline phosphatase (nº x) 0.662±0.083 (0.499–0.825) 0.047 0.81 56.2 74.6
Fasting Glycemia (mg/dL) 0.565±0.080 (0.408–0.721) 0.424 – – –
Insulin (uUI/mL) 0.666±0.081 (0.508–0.825) 0.041 17.10 50.0 82.5
HOMA-IR 0.669±0.080 (0.512–0.826) 0.038 3.28 50.0 80.9
Total Cholesterol (mg/dL) 0.466±0.074 (0.320–0.612) 0.678 – – –
HDL-cholesterol (mg/dL) 0.649±0.087 (0.477–0.820) 0.067 – – –
LDL-cholesterol (mg/dL) 0.415±0.069 (0.279–0.550) 0.294 – – –
Triglycerides (mg/dL) 0.635±0.089 (0.460–0.810) 0.683 – – –
Waist circumference (cm) 0.586±0.074 (0.440–0.732) 0.289 – – –
Body mass index(kg/m2) 0.536±0.076 (0.386–0.686) 0.661 – – –
Body fat (%) 0.450±0.075 (0.303–0.597) 0.538 – – –
Subcutaneous fat (cm) 0.467±0.085 (0.300–0.633) 0.683 – – –
Hepatic fat content 0.675±0.71  (0.536–0.815) 0.003 56 81.2 55.5
Table 3 - Effectiveness of biochemical, anthropometric, and body composition indicators and of the liver fat index in identifying 
hepatic steatosis 
In the analysis of the ROC curve, liver enzymes (ALT, 
GG,T and ALP), HOMA -IR index, and FLI showed areas 
under the curve (AUC) significant (p<0.05) for the predic-
tion of HS (Table 3). On the other hand, anthropometric and 
body composition indicators, plasma lipid profile, fasting 
glucose, and AST showed no significant results. The most 
accurate cutoff points for variables with significant results 
are shown in Table 3.
The concordance analysis between the diagnoses 
of HS by US and by FLI demonstrated a kappa index of 
0.23, indicating little agreement between the methods. 
The chi-square test showed a correlation between both 
methods for the diagnosis of HS (6.924; p<0.009). Ado-
lescents with a diagnosis of HS by FLI were five times 
more likely to show the HS by US. (OR 5.42; 95%CI 
1.404–20.898).
Discussion
The present study found a prevalence of HS of 20.3% 
in the studied population. The prevalence of HS is poorly 
understood and it may be related to the method used 
for diagnosis. The studies used elevated ALT levels as 
a criterion or the comparison of the echogenicity of the 
hepatic parenchyma with the renal cortex, the latter being 
more hyperechogenic in relation to the adjacent kidney. 
Studies show prevalence in obese children and adolescents 
from 15 to 42%(11,12). The prevalence of NAFLD more than 
doubled in the past 20 years, rising from 3.9% in 1988 to 
10.7% in 2010 in U.S. adolescents(13). Based on autopsy 
studies, Schwimmer et al(14) reported that the prevalence 
of HS in children and adolescents was of 9.6% and this 
prevalence rose to 38% in obese individuals. The  dif-
ference in prevalence may be related to the degree of 
obesity, because in some studies with higher prevalence, 
mean BMI values are higher compared to studies with 
lower prevalence.
Abdominal ultrasonography is considered a good 
method for the diagnosis and monitoring of the degree 
of fatty infiltration in the liver, although it does not 
correlate with the degree of fibrosis. We adopted this 
method of image due to the good sensitivity (89%) and 
specificity (94%) for detection of HS compared to liver 
biopsy, considered as the gold standard(15), besides having 
a relatively low cost, being noninvasive, easy to apply, 
and available in most services.
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The prevalence of IR assessed by the HOMA-IR index, 
found in this study was 29.1%. Published data reported 
prevalence rates higher in obese adolescents(16,17). This varia-
tion in the prevalence of IR in the studies may be explained 
by the lack of an established cutoff point as a reference to 
classify patient outcomes(6-18).
HS seems to relate directly to IR. The mean for the 
HOMA-IR index in this study was significantly higher in 
patients with HS. The HOMA-IR was shown to be a good 
indicator in predicting HS, with a cutoff of 3.28, close to that 
used for diagnosing IR (HOMA-IR >3.16). There is increas-
ing evidence that obesity and IR are risk factors for NAFLD 
also in children and adolescents. Seixas(19) demonstrated that 
obese children and adolescents with SH are 2.6-fold more 
likely to present IR when compared with children without 
HS. El-Koofy et al(20) observed that the prevalence of IR was 
significantly higher in patients with HS compared with 
patients without HS (73 versus 28%).
Insulin resistance and oxidative stress appear to be 
the two events involved in the pathogenesis of NAFLD. 
The pathophysiology involves two steps: first, IR causes 
steatosis; in the second, oxidative stress produces lipid 
peroxidation and active inflammatory cytokines, resulting 
in steatohepatitis(21). The state of insulin resistance, often 
associated with obesity, leads to increased circulating free 
fatty acids that are seized and deposited within hepato-
cytes. This deposit activates the inflammatory cascade 
modulated by a variety of cytokines, and results in the 
exacerbation of oxidative stress, critical to the progression 
of NAFLD(3). This hypothesis was confirmed in the study by 
Ruiz-Extremera et al(22), in which it was observed in obese 
adolescents, that oxidative stress and IR are significant 
factors for the development of HS. Mager et al(23) suggest 
that in all children and adolescents with overweight and 
obesity and that present IR, HS should be investigated.
In the comparison of means between groups with 
an without HS, the results of liver enzymes ALT, ALP, 
and GGT, presented as the number of times the upper 
limit of normal values, showed significant values. In the 
analysis of the ROC curve, the GGT showed greater speci-
ficity in the prediction of the HS, with a cutoff point 1.06 
times higher than the reference value. ALT showed greater 
sensitivity, with a cutoff of 0.54 times — value below the 
reference value. As the cutoff is defined as the highest sum 
of sensitivity and specificity, when the cutoff of ALT rises 
to 1, the sensitivity decreases to 31.2%, indicating not 
being a good predictor of HS. The study by Ramos(24) cor-
roborates the findings in the present study. In his research, 
the mean values of GGT were also associated to HS, but no 
enzyme presented a good cutoff point to predict the HS. 
The author also highlights the importance of performing 
ultrasonography in children and adolescents as a criterion 
to evaluate HS.
Some studies have shown that changes in ALT and GGT 
can relate to some degree of liver inflammation, character-
izing a more advanced stage of NAFLD(25,26). Therefore, it is 
recommended that even in the absence of changes in serum 
levels of liver enzymes, the ultrasound integrate the overall 
assessment of the obese patient to identify mild cases of 
hepatic fatty infiltration.
The means of anthropometric indicators and body com-
position, and lipid profile showed no significant difference 
between groups, and neither did the ROC curve analysis. 
This can be explained by the fact that patients in this study 
were from a clinic that treats severer cases of obesity, all of 
which with BMI, WC, and %BF above the recommended, 
regardless of HS. El-Koofy et al(20) observed a significant 
difference in the means of groups with and without HS for 
BMI, WC, and lipid profile. However, it is noteworthy that 
liver biopsy was the method used for the diagnosis of NAFLD 
and that, as inclusion criteria, all patients had to present 
hepatomegaly and/or abnormalities on ALT, indicating a 
more advanced stage of liver disease. The authors diagnosed 
44% of patients with NAFLD, a much higher prevalence 
than that found in the present study. In contrast, the results 
of Duarte and Silva(12) and Lin et al(27) agree with the present 
study, with no significant difference in lipid profile between 
groups with and without HS.
The FLI showed little relation to the diagnosis of HS 
by US. This index uses three variables for the calculation 
(GGT, TG and WC), and two of these variables (TG and 
WC) showed no statistical difference between the groups 
with and without HS, which could be the explanation for 
the poor agreement between the methods. This is the first 
study that made reference to FLI in obese adolescents and 
due to the low concordance with the US, it was considered 
of little use in the studied population.
In conclusion, patients with elevated GGT and/or 
HOMA-IR >3.28 should undergo US examination with 
great probability of obtaining HS as a result. The  FLI 
showed little association with the US, proving not to be a 
good method for the diagnosis of HS in obese adolescents.
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